Preetesh Jain (P Jain)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 45

Top Topics

Multiple Myeloma

Tyrosine Kinase

Artificial Intelligence

Prognostic Factors

Top Venues

American journal of hematology

Blood cancer journal

British journal of haematology

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Preetesh Jain, Fatima Zahra Jelloul
Biclonal mantle cell lymphoma. Blood 143 (21) (2024)
Anath C Lionel, Ashwath Gurumurthi, Ahmed Fetooh, Rami Eldaya, Sairah Ahmed, Swaminathan P Iyer, Loretta J Nastoupil, Jason Westin, Ranjit Nair, Luis Fayad, Luis Malpica, Sudhakar Tummala, Christopher Flowers, Sattva S Neelapu, Michael L Wang, Preetesh Jain
Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement. Leukemia & lymphoma 65 (5) (2024)
Anath C Lionel, Ashwath Gurumurthi, Ahmed Fetooh, Rami Eldaya, Sairah Ahmed, Swaminathan P Iyer, Loretta J Nastoupil, Jason Westin, Ranjit Nair, Luis Fayad, Luis Malpica, Sudhakar Tummala, Christopher Flowers, Sattva S Neelapu, Michael L Wang, Preetesh Jain
Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement. Leukemia & lymphoma (2024)
Rongjia Zhang, Susan Y Wu, Preetesh Jain, Chi Young Ok, Fangfang Yan, Wendy Chen, Onyeka Oriabure, Bouthaina Shbib Dabaja, Jillian R Gunther, Penny Fang, Chelsea Pinnix, Michael L Wang, Charles Gaulin
Characteristics, treatment, and outcomes of mantle cell lymphoma with cutaneous involvement: a decade-long study at MD Anderson cancer center. Leukemia & lymphoma (2024)
Anath C Lionel, Ashwath Gurumurthi, Ahmed Fetooh, Rami Eldaya, Sairah Ahmed, Swaminathan P Iyer, Loretta J Nastoupil, Jason Westin, Ranjit Nair, Luis Fayad, Luis Malpica, Sudhakar Tummala, Christopher Flowers, Sattva S Neelapu, Michael L Wang, Preetesh Jain
Efficacy and safety of brexucabtagene autoleucel CAR T-cell therapy with BTK inhibitors in the treatment of relapsed mantle cell lymphoma with central nervous system involvement. Leukemia & lymphoma 65 (5) (2024)
Preetesh Jain, Fatima Zahra Jelloul
Biclonal mantle cell lymphoma. Blood 143 (21) (2024)
Yuxuan Che, Yang Liu, Yixin Yao, Holly A Hill, Yijing Li, Qingsong Cai, Fangfang Yan, Preetesh Jain, Wei Wang, Lixin Rui, Michael L Wang
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations. Blood cancer journal 13 (1) (2023)
Christoph K Stein-Thoeringer, Neeraj Y Saini, Eli Zamir, Viktoria Blumenberg, Maria-Luisa Schubert, Uria Mor, Matthias A Fante, Sabine Schmidt, Eiko Hayase, Tomo Hayase, Roman Rohrbach, Chia-Chi Chang, Lauren McDaniel, Ivonne Flores, Rogier Gaiser, Matthias Edinger, Daniel Wolff, Martin Heidenreich, Paolo Strati, Ranjit Nair, Dai Chihara, Luis E Fayad, Sairah Ahmed, Swaminathan P Iyer, Raphael E Steiner, Preetesh Jain, Loretta J Nastoupil, Jason R Westin, Reetakshi Arora, Michael L Wang, Joel Turner, Meghan Menges, Melanie Hidalgo-Vargas, Kayla Reid, Peter Dreger, Anita Schmitt, Carsten Muller-Tidow, Frederick L Locke, Marco L Davila, Richard E Champlin, Christopher R Flowers, Elizabeth J Shpall, Hendrik Poeck, Sattva S Neelapu, Michael Schmitt, Marion Subklewe, Michael D Jain, Robert R Jenq, Eran Elinav
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy. Nature medicine (2023)
Yucai Wang, Preetesh Jain, Frederick L Locke, Matthew John Maurer, Matthew J Frank, Javier L Muñoz, Saurabh Dahiya, Amer M Beitinjaneh, Miriam T Jacobs, Joseph P McGuirk, Julie M Vose, Andre H Goy, Charalambos Andreadis, Brian T Hill, Kathleen A Dorritie, Olalekan O Oluwole, Abhinav Deol, Jonas Paludo, Bijal Shah, Trent P Wang, Rahul Banerjee, David Bernard Miklos, Aaron P Rapoport, Lazaros Lekakis, Armin Ghobadi, Sattva S Neelapu, Yi Lin, Michael L Wang, Michael D Jain
Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Yuxuan Che, Yang Liu, Yixin Yao, Holly A Hill, Yijing Li, Qingsong Cai, Fangfang Yan, Preetesh Jain, Wei Wang, Lixin Rui, Michael L Wang
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations. Blood cancer journal 13 (1) (2023)
Yuxuan Che, Yang Liu, Yixin Yao, Holly A Hill, Yijing Li, Qingsong Cai, Fangfang Yan, Preetesh Jain, Wei Wang, Lixin Rui, Michael L Wang
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations. Blood cancer journal 13 (1) (2023)
Yuxuan Che, Yang Liu, Yixin Yao, Holly A Hill, Yijing Li, Qingsong Cai, Fangfang Yan, Preetesh Jain, Wei Wang, Lixin Rui, Michael L Wang
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations. Blood cancer journal 13 (1) (2023)
Yuxuan Che, Yang Liu, Yixin Yao, Holly A Hill, Yijing Li, Qingsong Cai, Fangfang Yan, Preetesh Jain, Wei Wang, Lixin Rui, Michael L Wang
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations. Blood cancer journal 13 (1) (2023)
Preetesh Jain, Krystle Nomie, Nikita Kotlov, VitaIy Segodin, Holly Hill, Chi Young Ok, Ahmed Fetooh, Rashmi Kanagal-Shamana, Francisco Vega, Alexander Bagaev, Nathan Hale Fowler, Christopher R Flowers, Michael Wang
Immune-depleted tumor microenvironment is associated with poor outcomes and BTK inhibitor resistance in mantle cell lymphoma. Blood cancer journal 13 (1) (2023)
Yuxuan Che, Yang Liu, Yixin Yao, Holly A Hill, Yijing Li, Qingsong Cai, Fangfang Yan, Preetesh Jain, Wei Wang, Lixin Rui, Michael L Wang
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations. Blood cancer journal 13 (1) (2023)
Holly A Hill, Preetesh Jain, Chi Young Ok, Koiji Sasaki, Han-Yang Chen, Michael L Wang, Ken Chen
Integrative Prognostic Machine Learning Models in Mantle Cell Lymphoma. Cancer research communications 3 (8) (2023)
Yuxuan Che, Yang Liu, Yixin Yao, Holly A Hill, Yijing Li, Qingsong Cai, Fangfang Yan, Preetesh Jain, Wei Wang, Lixin Rui, Michael L Wang
Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations. Blood cancer journal 13 (1) (2023)
Preetesh Jain, Michael L Wang
Mantle cell lymphoma in 2022-A comprehensive update on molecular pathogenesis, risk stratification, clinical approach, and current and novel treatments. American journal of hematology 97 (5) (2022)
Neeraj Y Saini, David M Swoboda, Uri Greenbaum, Junsheng Ma, Romil D Patel, Kartik Devashish, Kaberi Das, Mark R Tanner, Paolo Strati, Ranjit Nair, Luis Fayad, Sairah A Ahmed, Hun Ju Lee, Swaminathan P Iyer, Raphael E Steiner, Nitin Jain, Loretta Nastoupil, Sanam Loghavi, Guilin Tang, Roland L Bassett, Preetesh Jain, Michael L Wang, Jason R Westin, Michael R Green, David A Sallman, Eric Padron, Marco L Davila, Frederick L Locke, Richard E Champlin, Guillermo Garcia-Manero, Elizabeth J Shpall, Partow Kebriaei, Christopher R Flowers, Michael D Jain, Feng Wang, Andrew P Futreal, Nancy Gillis, Sattva S Neelapu, Koichi Takahashi
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma. Blood cancer discovery 3 (5) (2022)
Preetesh Jain, Shuangtao Zhao, Jee Hun Lee, Holly A Hill, Chi Young Ok, Rashmi Kanagal-Shamana, Fredrick B Hagemeister, Nathan Fowler, Luis Fayad, Yixin Yao, Yang Liu, Omar B Moghrabi, Lucy Navsaria, Lei Feng, Graciela M Nogueras Gonzalez, Guofan Xu, Selvi Thirumurthi, David A Santos, Cezar Iliescu, Guillin Tang, L Jeffrey Medeiros, Francisco Vega, Michelle Avellaneda, Maria Badillo, Christopher R Flowers, Linghua Wang, Michael L Wang
Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Preetesh Jain, Rashmi Kanagal-Shamanna, Shaojun Zhang, Chi Young Ok, Lucy Navsaria, Loretta Nastoupil, Hun Ju Lee, Guillin Tang, Cheng Cameron Yin, Maria Badillo, Ranjit Nair, Shaoying Li, Keyur M Patel, Christopher Flowers, Francisco Vega, Linghua Wang, Michael L Wang
Outcomes of relapsed mantle cell lymphoma patients after discontinuing acalabrutinib. American journal of hematology 96 (5) (2021)
Hans C Lee, Lei Feng, Onyeka Oriabure, Vivian Graham, Wendy Chen, Maria Badillo, Rebecca Lu, Hun J Lee, Preetesh Jain, Elisabet E Manasanch, Robert Z Orlowski, Michael L Wang
A phase one trial of carfilzomib, bendamustine, and dexamethasone in relapsed and/or refractory multiple myeloma. American journal of hematology 96 (7) (2021)
Elisabet E Manasanch, Preetesh Jain, Wendy Chen, Onyeka Oriabure, Maria Badillo, Lei Feng, Zuzana Berkova, Robert Z Orlowski, Michael L Wang
Phase I/II study of high dose pomalidomide with G-CSF support and dexamethasone in patients with relapsed/refractory multiple myeloma. American journal of hematology 95 (9) (2020)
Preetesh Jain, Xiaohong Iris Wang
Carcinocythemia-Cancer cell leukemia. American journal of hematology 96 (3) (2020)
Preetesh Jain, Guillin Tang, Shaoying Li, Michael L Wang
"Triple hit" SOX11- , MME+ , TP53 mutated high-grade pleomorphic mantle cell lymphoma. American journal of hematology 96 (1) (2020)
Preetesh Jain, Martin Dreyling, John Francis Seymour, Michael Wang
High-Risk Mantle Cell Lymphoma: Definition, Current Challenges, and Management. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (36) (2020)
Collin K Chin, K J Lim, Katharine Louise Lewis, Preetesh Jain, Y Qing, L Feng, C Y Cheah, John Francis Seymour, David S Ritchie, K Burbury, Constantine S Tam, Nathan Hale Fowler, L E Fayad, J R Westin, S S Neelapu, F B Hagemeister, Felipe Samaniego, C R Flowers, L J Nastoupil, M J Dickinson
Autologous stem cell transplantation for untreated transformed indolent B-cell lymphoma in first remission: an international, multi-centre propensity-score-matched study. British journal of haematology 191 (5) (2020)
Preetesh Jain, Hagop Kantarjian, Prajwal C Boddu, Graciela Nogueras Gonzalez, Srdan Verstovsek, Guillermo Garcia-Manero, Gautam Borthakur, Koji Sasaki, Tapan M Kadia, Princy Sam, Hycienth Ahaneku, Susan O'Brien, Zeev Estrov, Farhad Ravandi, Elias Jabbour, Jorge E Cortes
Analysis of cardiovascular and arteriothrombotic adverse events in chronic-phase CML patients after frontline TKIs. Blood advances 3 (6) (2020)
Koiji Sasaki, Elias J Jabbour, Farhad Ravandi, Marina Y Konopleva, Gautam Borthakur, William G Wierda, Naval G Daver, Koichi Takahashi, Kiran Naqvi, Courtney D D DiNardo, Guillermo Montalban Bravo, Rashmi Kanagal-Shamana, Ghayas Issa, Preetesh Jain, Jeffrey Skinner, Mary B Rios, Sherry Pierce, Kelly A Soltysiak, Junya Sato, Guillermo Garcia Manero, Jorge E Cortes
The LEukemia Artificial Intelligence Program (LEAP) in chronic myeloid leukemia in chronic phase: A model to improve patient outcomes. American journal of hematology 96 (2) (2020)
Shuangtao Zhao, Rashmi Kanagal-Shamanna, Lucy Navsaria, Chi Young Ok, Shaojun Zhang, Krystle Nomie, Guangchun Han, Dapeng Hao, Holly A Hill, Changying Jiang, Yixin Yao, Loretta Nastoupil, Jason Westin, Luis Fayad, Ranjit Nair, Raphel Steiner, Sairah Ahmed, Felipe Samaniego, Swaminathan P Iyer, Onyeka Oriabure, Wendy Chen, Xingzhi Song, Jianhua Zhang, Maria Badillo, Omar Moghrabi, Jorge Aranda, Guillin Tang, Cheng Cameron Yin, Keyur Patel, Leonard Jeffrey Medeiros, Shaoying Li, Francisco Vega, Selvi Thirumurthi, Guofan Xu, Sattva Neelapu, Christopher R Flowers, Jorge Romaguera, Nathan Fowler, Linghua Wang, Michael L Wang, Preetesh Jain
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients. American journal of hematology 95 (6) (2020)
Preetesh Jain, Loretta Nastoupil, Jason Westin, Hun Ju Lee, Lucy Navsaria, Raphael E Steiner, Sairah Ahmed, Omar Moghrabi, Onyeka Oriabure, Wendy Chen, Maria Badillo, Christopher R Flowers, Michael L Wang
Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy. British journal of haematology 192 (2) (2020)
Preetesh Jain, Michael L Wang
Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. American journal of hematology 94 (6) (2019)
Preetesh Jain, Jorge E Romaguera, Samer A Srour, Hun J Lee, Frederick Hagemeister, Jason Westin, Luis Fayad, Felipe Samaniego, Maria Badillo, Liang Zhang, Lorreta Nastoupil, Rashmi Kanagal-Shamana, Nathan Fowler, Michael L Wang
Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL). British journal of haematology 182 (3) (2018)
Preetesh Jain, Rashmi Kanagal-Shamanna, Sergej Konoplev, Zhuang Zuo, Zeev Estrov
Biclonal IGHV-4-34 hairy cell leukemia variant and CLL - successful treatment with ibrutinib and venetoclax. American journal of hematology 93 (12) (2018)
Rashmi Kanagal-Shamana, Preetesh Jain, Keyur P Patel, Mark Routbort, Carlos Bueso-Ramos, Tahani Alhalouli, Joseph D Khoury, Rajyalakshmi Luthra, Alessandra Ferrajoli, Michael Keating, Nitin Jain, Jan Burger, Zeev Estrov, William Wierda, Hagop M Kantarjian, L Jeffrey Medeiros
Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation. Cancer 125 (4) (2018)
Preetesh Jain, Rashmi Kanagal-Shamanna, Shaojun Zhang, Makhdum Ahmed, Ahmad Ghorab, Liang Zhang, Chi Young Ok, Shaoying Li, Frederick Hagemeister, Dongfeng Zeng, Tiejun Gong, Wendy Chen, Maria Badillo, Krystle Nomie, Luis Fayad, Leonard J Medeiros, Sattva Neelapu, Nathan Fowler, Jorge E Romaguera, Richard Champlin, Linghua Wang, Michael L Wang
Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib. British journal of haematology 183 (4) (2018)
Eric Fountain, Haleigh Mistry, Preetesh Jain, Madeleine Duvic, Nathan Hale Fowler
Response to pembrolizumab and lenalidomide in advanced refractory mycosis fungoides. Leukemia & lymphoma 60 (4) (2018)
Yasmin M Abaza, Hagop M Kantarjian, Stefan Faderl, Elias J Jabbour, Nitin Jain, Deborah Thomas, Tapan Mahendra Kadia, Gautam Borthakur, Joseph D Khoury, Jan Burger, William Wierda, Susan O'Brien, Marina Konopleva, Alessandra Ferrajoli, Partow Kebriaei, Bouthaina Dabaja, Steven Kornblau, Yesid Alvarado, Naval Daver, Naveen Pemmaraju, Prithviraj Bose, Philip Thompson, Hind Al Azzawi, Mary Kelly, Rebecca Garris, Preetesh Jain, Guillermo Garcia-Manero, Jorge Cortes, Farhad Ravandi
Hyper-CVAD plus nelarabine in newly diagnosed adult T-cell acute lymphoblastic leukemia and T-lymphoblastic lymphoma. American journal of hematology 93 (1) (2017)
Preetesh Jain, Rashmi Kanagal-Shamanna, F Anthony San Lucas, Loretta Nastoupil, Jorge Romaguera, Luis Fayad, Yasuhiro Oki, Jason R Westin, Leonard Jeffrey Medeiros, Michael Wang, Nathan Fowler
Clinicopathological characteristics, outcomes and pattern of mutations in patients with follicular lymphoma who progressed on Bruton tyrosine kinase inhibitors. British journal of haematology 182 (5) (2017)
Preetesh Jain, Jan A Burger, Joseph D Khoury
CLL progression after one cycle of FCR: Richter's transformation versus EBV-associated lympho-proliferation. American journal of hematology 92 (10) (2017)
Preetesh Jain, Hagop M Kantarjian, Nitin Jain, Nicholas James Short, Cameron C Yin, Rashmi Kanagal-Shamana, Joseph Khoury, Marina Konopleva, Koji Sasaki, Tapan M Kadia, Rebecca Garris, Sherry Pierce, Zeev Estrov, William Wierda, Jorge Cortes, Susan O'Brien, Farhad Ravandi, Elias J Jabbour
Clinical characteristics and outcomes of previously untreated patients with adult onset T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma with hyper-CVAD based regimens. American journal of hematology 92 (10) (2017)
Koiji Sasaki, Hagop M Kantarjian, Susan M O'Brien, Farhad Ravandi, Marina Konopleva, Gautam Borthakur, Guillermo Garcia-Manero, William Wierda, Naval G Daver, Alessandra Ferrajoli, Koichi Takahashi, Preetesh Jain, Mary Beth Rios, Sherry Pierce, Elias J Jabbour, Jorge E Cortes
Prediction for sustained deep molecular response of BCR-ABL1 levels in patients with chronic myeloid leukemia in chronic phase. Cancer 124 (6) (2017)
Preetesh Jain, Hagop M Kantarjian, Ahmad Ghorab, Koiji Sasaki, Elias J Jabbour, Graciela Nogueras Gonzalez, Rashmi Kanagal-Shamana, Ghayas C Issa, Guillermo Garcia-Manero, Devendra Kc, Sara Dellasala, Sherry Pierce, Marina Konopleva, William G Wierda, Srdan Verstovsek, Naval G Daver, Tapan Mahendra Kadia, Gautam Borthakur, Susan M O'Brien, Zeev Estrov, Farhad Ravandi, Jorge E Cortes
Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients. Cancer 123 (22) (2017)
Preetesh Jain, Graciela M Nogueras González, Rashmi Kanagal-Shamanna, Uri Rozovski, Nawid Sarwari, Constantine Tam, William G Wierda, Philip A Thompson, Nitin Jain, Rajyalakshmi Luthra, Andrés E Quesada, Gabriela Sanchez-Petitto, Alessandra Ferrajoli, Jan Burger, Hagop Kantarjian, Jorge Cortes, Susan O'Brien, Michael J Keating, Zeev E Estrov
The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab. British journal of haematology 180 (1) (2017)
Rashmi Kanagal-Shamana, Preetesh Jain, Koichi Takahashi, Nicholas James Short, Guilin Tang, Ghayas C Issa, Farhad Ravandi, Guillermo Garcia-Manero, Cameron C Yin, Rajyalakshmi Luthra, Keyur P Patel, Joseph D Khoury, Guillermo Montalban-Bravo, Koiji Sasaki, Tapan Mahendra Kadia, Gautam Borthakur, Marina Konopleva, Nitin Jain, Rebecca Garris, Sherry Pierce, William Wierda, Zeev Estrov, Jorge Cortes, Susan M O'Brien, Hagop M Kantarjian, Elias Jabbour
TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens. Cancer 123 (19) (2017)